1. Home
  2. OLMA vs SOC Comparison

OLMA vs SOC Comparison

Compare OLMA & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • SOC
  • Stock Information
  • Founded
  • OLMA 2006
  • SOC 2020
  • Country
  • OLMA United States
  • SOC United States
  • Employees
  • OLMA N/A
  • SOC N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • SOC
  • Sector
  • OLMA Health Care
  • SOC
  • Exchange
  • OLMA Nasdaq
  • SOC Nasdaq
  • Market Cap
  • OLMA 465.4M
  • SOC 2.1B
  • IPO Year
  • OLMA 2020
  • SOC N/A
  • Fundamental
  • Price
  • OLMA $6.10
  • SOC $22.28
  • Analyst Decision
  • OLMA Strong Buy
  • SOC Buy
  • Analyst Count
  • OLMA 5
  • SOC 3
  • Target Price
  • OLMA $26.25
  • SOC $25.00
  • AVG Volume (30 Days)
  • OLMA 1.2M
  • SOC 1.6M
  • Earning Date
  • OLMA 11-12-2024
  • SOC 11-14-2024
  • Dividend Yield
  • OLMA N/A
  • SOC N/A
  • EPS Growth
  • OLMA N/A
  • SOC N/A
  • EPS
  • OLMA N/A
  • SOC N/A
  • Revenue
  • OLMA N/A
  • SOC N/A
  • Revenue This Year
  • OLMA N/A
  • SOC N/A
  • Revenue Next Year
  • OLMA N/A
  • SOC $606.07
  • P/E Ratio
  • OLMA N/A
  • SOC N/A
  • Revenue Growth
  • OLMA N/A
  • SOC N/A
  • 52 Week Low
  • OLMA $5.56
  • SOC $10.11
  • 52 Week High
  • OLMA $16.78
  • SOC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 27.05
  • SOC 53.11
  • Support Level
  • OLMA $5.56
  • SOC $19.51
  • Resistance Level
  • OLMA $6.87
  • SOC $24.73
  • Average True Range (ATR)
  • OLMA 0.81
  • SOC 1.60
  • MACD
  • OLMA -0.28
  • SOC 0.12
  • Stochastic Oscillator
  • OLMA 10.12
  • SOC 58.60

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About SOC Sable Offshore Corp. Common Stock

Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California.

Share on Social Networks: